NCT03888911View on ClinicalTrials.gov

Benefit and Tolerability of IQP-LU-104 in Weight Loss

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

November 21, 2019

Study Completion Date

November 21, 2019

Conditions
OverweightObesity
Interventions
DIETARY_SUPPLEMENT

High dose IQP-LU-104 (5120mg)

1 sachet to be taken 2 times daily orally, together with 2 main meals

DIETARY_SUPPLEMENT

Low dose IQP-LU-104 (2560mg)

1 sachet to be taken 2 times daily orally, together with 2 main meals

DIETARY_SUPPLEMENT

Placebo

1 sachet to be taken 2 times daily orally, together with 2 main meals

Trial Locations (1)

10369

Analyze & Realize, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY